#AskBQ is BloombergQuint’s daily offering where market experts help investors make informed investment decisions in the equity market.
In today’s episode, Aditya Agarwala of Yes Securities, and Sharmila Joshi, an independent investment advisor, gave their views on Avenue Supermarts, Bhushan Steel, Biocon and ICICI Bank, among others .
Watch the complete show here:
Edited excerpts from the conversation:
Ramesh M: I’m planning to start a monthly equity SIP (systematic investment plan) on three large-cap stocks which have a potential to grow more in coming years. Can I get a few recommendations?
Sharmila Joshi: For the first stock, go with any one of Sun Pharma, Lupin Pharma or Dr. Reddy’s as we are seeing a recovery there. One stock which guarantees certain growth is HDFC Bank. The final one should be from metals or infra. It can be either Tata Steel or L&T.
Shivanj Nagpal: Is it a good opportunity to enter into any of the PSU bank stocks?
Sharmila Joshi: If one is willing to take the risk, Bank of Baroda or Punjab National Bank can be bought. Pick SBI if you want to be on the safe side.
Siva Kumar: What is the best price at which I can buy ICICI Bank for the long term?
Sharmila Joshi: One has to see the performance of the new management and take a call then.
Arvind Mohan Gupta: Should I buy Bhushan Steel and Uniply?
Sharmila Joshi: The future is uncertain and there are better players like Hindalco, JSW Steel, Tata Steel. Regarding Uniply, I wouldn’t recommend a fresh buy at this stage but hold it if you have already invested.
Vivek Kanojia: Holding Avenue Supermarts at Rs 1,212 and CDSL at Rs 321 with long-term view. Please advise which one should I add in SIP basis.
Sharmila Joshi: I find Avenue Supermarts a little expensive at current levels. I won’t recommend CDSL as well for an SIP. I won’t advice you to add further.
Shama: I have bought Bajaj Finserv at Rs 5,915. Should I hold for a week?
Sharmila Joshi: It will bounce a little. Wait till Monday but have a stop loss in place.
Saurabh Pathak: I have bought 4,000 shares of Mahindra CIE at an average rate of Rs 235. Should I hold or book profits?
Sharmila Joshi: I would advice you to have a 9-12 month perspective and hold the stock.
Bharat Ambani: What is your view on HDFC Standard Life for the long term?
Sharmila Joshi: If one sees a correction, then try to buy at that price.
Bharat Bhushan: I have bought 12,000 shares of KNR Constructions at an average rate of Rs 250 for long term. What should I do?
Sharmila Joshi: I would recommend hold for the moment for at least a week.
Mani Kanth: I hold 700 shares of SBI for intraday at Rs 262.70. Help me with the selling point.
Aditya Agarwala: Keep a stop loss at today’s low which is Rs 258. I’m looking a potential upside of Rs 265.
Siddarth Badrinath: Please give short-term views on Biocon.
Aditya Agarwala: I would recommend to stay away from Biocon at current levels as its looking weaker. Keep a stop at Rs 620 for down-side target of Rs 570-580 for a short trade.
Jim Mathew: Is it a good time to enter Madhucon Projects?
Aditya Agarwala: Stay away from the stock.
Advait Supnekar: I want to make a basket of steel stocks for long-term investing. I have chosen Prakash, JSPL and Sunflag. Can you please review and suggest if any changes are required?
Sharmila Joshi: JSPL looks fine. I don’t have a view on other two. I would add Hindalco and JSW Steel to it.
Vijay Kumar: What is your view on Dilip Buildcon?
Sharmila Joshi: It is a decent space to be in. You have to wait and watch for the ASM (additional surveillance mechanism) overhang to settle.
Abhinav Sinha: I bought 400 shares of PTC India at Rs 92. Should I book losses?
Aditya Agarwala: I would recommend the investor to book losses as the stock is making lower highs and lower lows.
Ujjwal Kumar: Can I enter into NMDC at current levels?
Aditya Agarwala: The charts are weak. Hindalco or JSW Steel are better bets.
Both guests might have recommended some of the stocks discussed in the show to their clients.
Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint’s digital and social media platforms provide views of only SEBI registered investment advisors/analysts.